Patent Assignment
Reel/Frame 053521/0132
Change of Name
Recorded: 2020-08-18
Pages: 2
Assignor
UCB BIOPHARMA SPRL
Executed: 2019-12-02
Assignee
UCB BIOPHARMA SRL
ALLEE DE LA RECHERCHE 60, BRUSSELS, 1070, BELGIUM
Covered Property
(1)
Gremlin-1 Inhibitor for the Treatment of a Bone Fracture or Bone Defect
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.